{"id":"W2944427520","doi":"10.1073/pnas.1819004116","title":"TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion","year":2019,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; Canadian Institutes of Health Research; Genentech; Government of Canada; Cancer Prevention and Research Institute of Texas","keywords":"Blockade; Ipilimumab; Cancer research; Ligand (biochemistry); Medicine; Cancer; Immune checkpoint; CTLA-4; Cancer immunotherapy; Antibody; Receptor; Melanoma; Immunotherapy; Immunology; Pharmacology; Internal medicine; Immune system; T cell","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001126841,0.00009145802,0.000242582,0.0001402201,0.00007880535,0.00001375035,0.0003231721,0.00006807495,0.00002628623],"category_scores_gemma":[0.0002943392,0.00005941237,0.0000974035,0.0007008495,0.0007050012,0.00025421,0.00004255365,0.000122141,8.887526e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003486498,"about_ca_system_score_gemma":0.00006575315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003047894,"about_ca_topic_score_gemma":5.391901e-8,"domain_scores_codex":[0.9983657,0.000006899274,0.0003685552,0.0001993132,0.0009267247,0.0001328348],"domain_scores_gemma":[0.9991499,0.0001142881,0.0005003224,0.00001014518,0.0001973507,0.00002804636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004390467,0.00007812661,0.02687023,0.0001230797,0.00002882165,4.453095e-9,0.0001027274,0.000001780433,0.9702534,0.001196557,0.000338553,0.0005676705],"study_design_scores_gemma":[0.0007316296,0.0001684614,0.1678301,0.0004102603,0.00002127818,0.00001570824,0.0001009992,0.0001090631,0.8295832,0.0007593054,0.0002133345,0.00005670414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933905,0.0005945215,2.6661e-7,0.001612149,0.00003040933,0.0002517854,0.00001089271,0.000008258125,0.004101189],"genre_scores_gemma":[0.9990331,0.0001360074,0.0003329247,0.0001937582,0.00006473974,0.000002673422,3.787284e-7,0.000004173953,0.0002322704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1409598,"threshold_uncertainty_score":0.2597606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01972953113304703,"score_gpt":0.2974859262997659,"score_spread":0.2777563951667189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}